Production of α-Bisabolol from metabolically engineered Escherichia coli

α-Bisabolol is a natural-occurring sesquiterpenoid with applications in cosmetics as whitening and soothing agent. It is synthesized from the universal precursors, isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP), which are generated either through the mevalonate (MVA) pathway or the 2C-methyl-D-erythritol-4-phosphate (MEP) pathway. Farnesyl pyrophosphate (FPP) synthase (IspA) then catalyzes the condensation of IPP and DMAPP to the linear FPP, which is rearranged and cyclized to α-bisabolol by bisabolol synthases. Here, we compared the capacity of 5 α-bisabolol synthases from Lippia dulcis, Streptomyces citricolor, Santalum spicatum, Matricaria recutita, and Artemisia annua for α-bisabolol production. MVA pathway and FPP synthase were also overexpressed to supply sufficient FPP for bisabolol synthesis in the recombinant E. coli. Bisabolol synthase from M. recutita (MrBBS) shows the highest activity of bisabolol synthesis, and 75 mg/L/OD600 of bisabolol was produced in a test-tube culture. We further optimized the expression level of IspA and MrBBS by modulation their RBS strength. The 24 bisabolol synthesis operons with different RBSs were assessed for their performance on bisabolol synthesis. By this approach, the best strain is able to produce bisabolol with a capacity of 220mg/L/OD600 in a test tube culture. The consequence of host strain optimization led to an increase in bisabolol production to 300 mg/L/OD600, which presents a 4-fold increase over the initial engineered strain. This work was supported by a grant (NRF-2016R1A2B2010678) from the National Research Foundation, MSIP, Korea

Commentary on: Incidental Breast Cancers Identified in a One-Stop Symptomatic Breast Clinic

In a recent study published in the Journal of Breast Cancer, Mehrotra et al. [1] reported incidental breast cancers identified in a one-stop symptomatic breast clinic where patients receive the results of their radiological examinations and tissue sampling on the same day. Medical environments differ from country to country and from culture to culture. Nevertheless, breast cancer is the most frequent cancer among women in developed and developing countries [2]. They reported 87.2 % symptomatic cancers and 12.8 % incidental cancers using a definition of symptomatic cancers as “breast cancers correlated to the patient’s symptoms ” and that of incidental cancers as “breast cancers detected only by imaging in a completely separate location to the site of presenting symptoms and not palpable by the clinician. ” In this study, the mean age of patients with symptomatic cancers and incidenta

Clinical outcomes for T1-2N0-1 oral tongue cancer patients underwent surgery with and without postoperative radiotherapy

BACKGROUND: The aim of this study was to assess the results of curative surgery with and without radiotherapy in patients with T1-2N0-1 oral tongue squamous cell carcinoma (OSCC) and to evaluate survival and prognostic factors. METHODS: Retrospective analysis of 86 patients with T1-2N0-1 OSCC who received surgery between January 2000 and December 2006. Fourteen patients (16.3%) received postoperative radiotherapy (PORT). Patient characteristics, tumor characteristics, treatment modality, failure patterns, and survival rates were analyzed. RESULTS: The median follow-up was 45 months. The five-year overall survival (OS) and disease-free survival (DFS) rates were 80.8% and 80.2%, respectively. Higher tumor grade and invasion depth > or = 0.5 cm were the significant prognostic factors affecting five-year OS and DFS (OS rate; 65% vs. 91%, p = 0.001 for grade; 66% vs. 92%, p = 0.01 for invasion depth: DFS rate; 69% vs. 88%, p = 0.005 for grade; 66% vs. 92%, p = 0.013 for invasion depth). In the risk group, there was no local failure in patients with postoperative radiotherapy. CONCLUSIONS: In T1-2N0-1 OSCC, factors that affected prognosis after primary surgery were higher tumor grade and deep invasion depth over 0.5 cm. Postoperative radiotherapy should be considered in early oral tongue cancer patients with these high-risk pathologic featuresope

Gastrointestinal hemangioma in childhood: a rare cause of gastrointestinal bleeding

Gastrointestinal (GI) hemangiomas are relatively rare benign vascular tumors. The choice of an appropriate diagnostic method depends on patient age, anatomic location, and presenting symptoms. However, GI hemangiomas are not a common suspected cause of GI bleeding in children because of their rarity. Based on medical history, laboratory results, and imaging study findings, the patient could be treated with either medication or surgery. Herein, we report 3 cases of GI hemangioma found in the small bowel, rectum, and GI tract (multiple hemangiomas). Better knowledge and understanding of GI hemangioma could help reduce the delayed diagnosis rate and prevent inappropriate management. Although rare, GI hemangiomas should be considered in the differential diagnosis of GI bleeding

A New Technique for Inferior Hypogastric Plexus Block: A Coccygeal Transverse Approach -A Case Report-

Chronic pelvic pain is a common problem with variable etiology. The sympathetic nervous system plays an important role in the transmission of visceral pain regardless of its etiology. Sympathetic nerve block is effective and safe for treatment of pelvic visceral pain. One of them, the inferior hypogastric plexus, is not easily assessable to blockade by local anesthetics and neurolytic agents. Inferior hypogastric plexus block is not commonly used in chronic pelvic pain patients due to pre-sacral location. Therefore, inferior hypogastric plexus is not readily blocked using paravertebral or transdiscal approaches. There is only one report of inferior hypogastric plexus block via transsacral approach. This approach has several disadvantages. In this case a favorable outcome was obtained by using coccygeal transverse approach of inferior hypogastric plexus. Thus, we report a patient who was successfully given inferior hypogastric plexus block via coccygeal transverse approach to treat chronic pelvic pain conditions involving the lower pelvic viscera

Correction: triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival

After the publication of this work [1], we found that there were some mistakes in calculating the percentage of composition in Table 1(1). Clinicopathologic characteristics of breast cancer subtypes. We are therefore providing the revised Table 1, with the updated data for rows Mucinous carcinoma, Metaplastic carcinoma and Others. In the sub-content of Table 1, Histological type, the total number of Others was corrected from 18 to 16, and the composition of Others type was slightly changed according to breast cancer subtypes. For IHC-Her2 subtype, the number of Others was changed from 4 to 3, and 6 cases which were previously unidentified were assigned to corresponding subtypes. One case to IHC-BLBC, 2 cases to IHC-QNBC/5NP and 3 cases to IHC-TNCB. There was no effect on statistical analysis with the correction.

Peliosis Hepatis with Hemorrhagic Necrosis and Rupture: a Case Report with Emphasis on the Multi-Detector CT Findings

We report here on an uncommon case of peliosis hepatis with hemorrhagic necrosis that was complicated by massive intrahepatic bleeding and rupture, and treated by emergent right lobectomy. We demonstrate the imaging findings, with emphasis on the triphasic, contrast-enhanced multidetector CT findings, as well as reporting the clinical outcome in a case of peliosis hepatis with fatal hemorrhage

Correction: triple-negative, basal-like, and quintuple-negative breast cancers: better prediction model for survival

After the publication of this work [1], we found that there were some mistakes in calculating the percentage of composition in Table 1(1). Clinicopathologic characteristics of breast cancer subtypes. We are therefore providing the revised Table 1, with the updated data for rows Mucinous carcinoma, Metaplastic carcinoma and Others. In the sub-content of Table 1, Histological type, the total number of Others was corrected from 18 to 16, and the composition of Others type was slightly changed according to breast cancer subtypes. For IHC-Her2 subtype, the number of Others was changed from 4 to 3, and 6 cases which were previously unidentified were assigned to corresponding subtypes. One case to IHC-BLBC, 2 cases to IHC-QNBC/5NP and 3 cases to IHC-TNCB. There was no effect on statistical analysis with the correction.